MedPath

QINLOCK

QINLOCK

Approved
DIN Number

02500833

Drug Class

Human

Market Date

Dec 10, 2020

Company
HC

deciphera pharmaceuticals. llc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02500833
AIG Number0162315001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX19 RIPRETINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIPRETINIBActive
Strength: 50 MG
Monograph: RIPRETINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.